Gemifloxacin - CISMeF

Preferred Label : Gemifloxacin;

MeSH definition : A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.;

MeSH hyponym : SB265805; SB 265805; LB-20304; LB20304;

MeSH CAS label : 1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-;

MeSH Related Number : 175463-14-6 (Gemifloxacin); X4S9F8RL01;

UNII : OKR68Y0E4T;

Details

Origin ID

D000077735;

UMLS CUI

C0533545;

ATC code(s)
- gemifloxacin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Gemifloxacin [ICD-11 Extension code]
- Gemifloxacin Mesylate [NCIt concept]
- Gemifloxacin mesilate (substance) [SNOMED CT concept]
- Product containing gemifloxacin (medicinal product) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Gemifloxacin [LOINC component]
- Gemifloxacin [NCIt concept]
- Gemifloxacin (substance) [SNOMED CT concept]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
- topoisomerase II inhibitors [MeSH Descriptor]
Record concept(s)
- 7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid [MeSH concept]
- LB 20304 [MeSH concept]
- SB-265805 [MeSH concept]
- factive [MeSH concept]
- gemifloxacin [MeSH concept]
- gemifloxacin mesylate [MeSH concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Gemifloxacin [LOINC component]
- Gemifloxacin [NCIt concept]
- Gemifloxacin (substance) [SNOMED CT concept]
- Product containing gemifloxacin (medicinal product) [SNOMED CT concept]
- gemifloxacin [ATC Code]
Validated automatic mappings to BTNT
- gemifloxacin [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients